Summary
Association between SNPs in polymorphism in proliferator-activated receptor-gamma (PPARG) and peak bone mineral density (BMD) variation of women was measured in 401 Chinese nuclear families using quantitative transmission
disequilibrium test (QTDT). The peak BMD variation was not attributable to PPARG in our sample.
Introduction
The purpose of this study is to test whether genetic PPARG might play a role in normal variation in peak BMD.
Methods
We genotyped 10 tagging SNPs in PPARG using allele-specific polymerase chain reaction and further test whether these SNPs were associated with peak BMD variation
at the lumbar spine and femoral neck of women in 401 Chinese nuclear families using QTDT. Furthermore, the association between
these SNPs in PPARG and BMD in 710 postmenopausal Chinese women was measured.
Results
Using QTDT for within-family association, we failed to find that single SNP and haplotype were significantly associated with
peak BMD at the lumbar spine and femoral neck. Meanwhile, we found that only rs1801282 was significantly associated with BMD
at the lumbar spine in postmenopausal women (P = 0.013).
Conclusions
Our present results suggest, for the first time, that the genetic polymorphism in PPARG is not a major contributor to the observed variability in peak BMD at the lumbar spine and femoral neck in Chinese women.
Keywords Bone mineral density - Polymorphism - Proliferator-activated receptor-gamma - Transmission disequilibrium test
An erratum to this article can be found at
http://dx.doi.org/10.1007/s00198-010-1196-3